The Saudi Food and Drug Authority (SFDA), in cooperation with the Ministry of Municipalities and Housing, has initiated comprehensive regulatory campaigns spanning diverse regions and cities across the Kingdom of Saudi Arabia. These campaigns, driven by a commitment to bolstering food safety during the holy month of Ramadan, focus on verifying the quality of commonly consumed food items during this period and ensuring their adherence to established health regulations.

To promote public health and encourage healthy dietary habits, the Saudi Food and Drug Authority (SFDA) has announced the adoption of three new technical regulations. These initiatives align with the Saudi Vision 2030 and support the SFDA's preventative efforts to increase life expectancy and reduce chronic disease rates. The regulations, effective July 1, 2025, mandate Caffeine Content Disclosure, High Salt Content Labeling, and Physical Activity Calorie Burn Labeling on menus of restaurants and cafes.

The Saudi Food and Drug Authority (SFDA) emphasizes that voluntary recalls, proactively initiated by food establishments to remove products from the market upon discovering or suspecting defects, are crucial for protecting consumer health and maintaining the quality and safety of food products.

The International Scientific Advisory Board (ISAB) convened its first meeting of 2025 at the Saudi Food and Drug Authority (SFDA) headquarters in Riyadh, Saudi Arabia. Held on February 19-20, 2025, the meeting was opened by Dr. Mohammed bin Ali Al-Nasser, SFDA Vice President for the Food Sector, who welcomed the international experts in food safety from the UK, Ireland, Australia, Italy, and South Korea.

As part of the SFDA ongoing efforts to enhance global partnerships and ensure the highest standards of food and drug safety, H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), met today with H.E. Ms. Sandra Gallina, Director-General for Health and Food Safety for the European Commission, at the Commission’s headquarters in Brussels. The meeting was also attended by H.E. Ms. Haifa Al Jedaie, Ambassador of the Kingdom of Saudi Arabia to the European Union. 

The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey today opened a roundtable meeting in Brussels, bringing together key European officials and business leaders. Participants included representatives from the European Commission's Directorates-General for Health and Food Safety, Agriculture and Rural Development, and Trade, along with members of relevant European Council working groups and CEOs of leading European companies operating in sectors aligned with the SFDA's remit.

In a major step toward advancing Saudi-European trade and regulatory collaboration, H.E. Dr. Hisham S. Aljadhey, Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), held high-level meetings today with H.E. Luigi Di Maio, European Union (EU) Special Representative for the Gulf Region, and Dr. Sabine Weyand, Director General of the EU Directorate-General for Trade. Saudi Ambassador to the EU, Ms. Haifa Al Jedaie, was also present, reinforcing the Kingdom’s commitment to deepening economic and regulatory ties with the EU.

The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, led the Kingdom of Saudi Arabia's delegation at the Ninth Meeting of the Gulf Cooperation Council (GCC) Ministerial Committee for Food Safety, held today in the State of Kuwait. The meeting was chaired by the Kuwaiti Minister of Health and Chairman of the current session, H.E. Dr. Ahmed Abdul Wahab Al-Awadhi, and attended by the Secretary-General of the GCC, H.E. Mr. H.E. Jasem Mohamed AlBudaiwi.

The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, contributed his insights to a prominent panel discussion on “Regulatory Pathways: Balancing Innovation and Safety” at the Global Healthspan Summit 2025 in Riyadh on Tuesday. The session centered on the pivotal role of regulatory frameworks in fostering innovation while ensuring public safety, particularly in efforts to extend healthy lifespans.